Search results for “Ribociclib” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 160 patents, we discovered top 51 key players by total patent application. Novartis AG, NATCO Pharma Ltd., Mylan Laboratories Ltd. are dominant in this area. They take 51.25% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 71
NATCO Pharma Ltd.
Andhra Pradesh, India
Patent: 6
Mylan Laboratories Ltd.
Telangana, India
Patent: 5
Apotex, Inc.
Ontario, Canada
Patent: 4
Olema Pharmaceuticals, Inc.
California, United States
Patent: 4
Fresenius Kabi Oncology Ltd.
Haryana, India
Patent: 4
Dr. Reddy's Laboratories Ltd.
Andhra Pradesh, India
Patent: 3
Pfizer Inc.
New York, United States
Patent: 2
Lupin Ltd
Maharashtra, India
Patent: 2
Shilpa Medicare Ltd.
Karnataka, India
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Biotx Ai GmbH
Berlin, Germany
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 120 patents applied in the last 5 years. We discover 45 most active companies in this area. The fast-growing Novartis AG, NATCO Pharma Ltd., Mylan Laboratories Ltd. take 40.00% of patent filing during this period.
Novartis AG
Basel-Stadt, Switzerland
Patent: 37
NATCO Pharma Ltd.
Andhra Pradesh, India
Patent: 6
Mylan Laboratories Ltd.
Telangana, India
Patent: 5
Apotex, Inc.
Ontario, Canada
Patent: 4
Olema Pharmaceuticals, Inc.
California, United States
Patent: 4
University of Tennessee Research Foundation
Tennessee, United States
Patent: 4
Fresenius Kabi Oncology Ltd.
Haryana, India
Patent: 3
Chang Gung University
Taiwan Province, China
Patent: 3
Shanghai Acrono Pharmaceutical Group Co., Ltd.
Shanghai Shi, China
Patent: 2
TEVA PHARMS USA
New Jersey, United States
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 120 patents in last 5 years, we discover 40 new entrants. NATCO Pharma Ltd., Mylan Laboratories Ltd., Apotex, Inc. are the most active new entrants in this area.
NATCO Pharma Ltd.
Andhra Pradesh, India
Patent: 6
Mylan Laboratories Ltd.
Telangana, India
Patent: 5
Apotex, Inc.
Ontario, Canada
Patent: 4
Olema Pharmaceuticals, Inc.
California, United States
Patent: 4
University of Tennessee Research Foundation
Tennessee, United States
Patent: 4
Chang Gung University
Taiwan Province, China
Patent: 3
Shanghai Acrono Pharmaceutical Group Co., Ltd.
Shanghai Shi, China
Patent: 2
TEVA PHARMS USA
New Jersey, United States
Patent: 2
Hangzhou SoliPharma Co., Ltd.
China
Patent: 2
Chongqing Sansheng Industrial Co., Ltd.
Chongqing Shi, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 20 patents, we discovered top 9 universities and scientific research institutions by total patent application. Chang Gung University, Donghua University, Guizhou University are dominant in this area. They take 45.00% of the total patent filing.
Chang Gung University
Taiwan Province, China
Patent: 3
Donghua University
Shanghai Shi, China
Patent: 2
Guizhou University
Guizhou Sheng, China
Patent: 2
Southwest University for Nationalities
Sichuan Sheng, China
Patent: 2
University of Hong Kong
Hong Kong SAR, China
Patent: 1
Sichuan University
Sichuan Sheng, China
Patent: 1
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 1
Zhejiang University of Technology
Zhejiang Sheng, China
Patent: 1
Dongguan University of Technology
Guangdong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: